- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02440906
Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project (WIN)
The Wellness Incentives and Navigation (WIN) project is designed to help improve health self-management and reduce the incidence and consequences of chronic disease among non-elderly adult Medicaid Supplemental Security Income (SSI) beneficiaries. WIN targets SSI beneficiaries with behavioral health (mental health and substance abuse) diagnoses. Research demonstrates that these individuals are more likely to suffer chronic physical co-morbidities, experience debilitating chronic illnesses earlier in life and have elevated healthcare costs.
WIN uses person-centered wellness planning and navigation facilitated by trained, professional health Navigators, dedicated specifically to the WIN project, who use Motivational Interviewing (MI) techniques, and a personal wellness account. Participants with more serious mental illnesses will be offered additional support in the form of Wellness Recovery Action Planning (WRAP) to enable them to take full advantage of person-centered wellness planning.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Texas based Wellness Incentives and Navigation (WIN) project uses a continuum of evidence-based "whole person" interventions that take into account clinical, environmental, and social risk factors and co-morbidities. Unlike more traditional didactic approaches to health management, WIN addresses individual behavioral, social, and economic barriers to health and wellness, and promotes continued engagement in achieving, internalizing, and maintaining healthy behaviors.
The study is focused on non-dual eligible adult STAR+PLUS (a Texas Medicaid managed care program for people with chronic illnesses) members (ages 21-55) with a behavioral health disorder including serious mental illness (SMI - e.g., schizophrenia, bipolar disorder or major depressive disorder) or other behavioral health conditions (e.g., anxiety disorder or substance abuse). Key features of the program include the use of professional health navigators, working in collaboration with the three STAR+PLUS plans in the Harris Service Area (SA) (United-Evercare, Amerigroup, and Molina), the use of motivational interviewing (MI) techniques to help members develop and meet personal wellness goals, and a flexible wellness account for the participant to use in meeting his/her goals.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32608
- University of Florida, Institute for Child Health Policy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be a resident of the Harris service area
- Be a non-dual eligible member of STAR+PLUS;
- Be 21 to 55 years of age; and
- Have an SMI Diagnosis (schizophrenia, bi-polar disorder, major depressive disorder); or
- Other behavioral health diagnoses (e.g., anxiety, depression, substance use disorder) coupled with a chronic health diagnosis (physical health condition).
Exclusion Criteria:
- Intellectual or cognitive diagnoses indicative of severe cognitive impairment. These could include diagnoses such as 290.X (dementia) and 318-319 (moderate to severe mental retardation).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
A person-centered wellness intervention that includes a patient-directed wellness account.
Enrollees meet with a patient Navigator to develop a wellness plan.
The enrollee can then use the flexible wellness account to make purchases that are consistent with the goals of the wellness plan.
Health Navigators have monthly phone contact with enrollees and meet quarterly with them to discuss goals and spending with the express goal of improving self-management, use of preventive services, satisfaction with care, healthcare utilization and expenditures and quality of care.
|
The intervention group (n=629) continue to receive usual care and receive a financial incentive to use in meeting their health goals.
The intervention group (n=629) will work with a health navigator on a monthly basis to develop and refine patient-centered health goals.
Motivational interviewing techniques are used to establish the wellness goals.
|
No Intervention: Control
Control group participants receive a monthly mailing requesting updated contact information.
They can send this card via mail, or by calling the toll free number.
|
|
No Intervention: Comparison
These are STAR+PLUS enrollees who meet the same enrollment criteria as the intervention and control but reside outside of the Harris Service Area.
The purpose of the comparison group is to follow them and their outcomes.
This group will help us to better compare the outcomes we see with those enrolled in the WIN Project to a comparable group for whom we already house data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported physical health related quality of life (HRQOL) using the Short Form-12 (SF-12)
Time Frame: (Change) baseline, 12 months, 24 months and 36 months
|
The SF-12 has been validated across a number of chronic diseases and conditions.
The survey consists of 12 questions measuring functional health and well-being.
Patients answer questions related to daily functioning, difficulties in physical tasks, and disruptions in life due to mental illness (e.g.
depression, anxiety).
The overall score can be further classified into two summary scores for physical and mental health.
|
(Change) baseline, 12 months, 24 months and 36 months
|
Self-reported mental health related quality of life (HRQOL) using the Short Form-12 (SF-12)
Time Frame: (Change) baseline, 12 months, 24 months and 36 months
|
The SF-12 has been validated across a number of chronic diseases and conditions.
The survey consists of 12 questions measuring functional health and well-being.
Patients answer questions related to daily functioning, difficulties in physical tasks, and disruptions in life due to mental illness (e.g.
depression, anxiety).
The overall score can be further classified into two summary scores for physical and mental health.
|
(Change) baseline, 12 months, 24 months and 36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Total Healthcare expenditures as measured through Medicaid claims data
Time Frame: (Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
We will use Medicaid claims and enrollment expenditure data to examine changes in total medical expenditures between the three groups of participants across baseline, 12 months, 24 months and 36 months.
|
(Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
Changes in Inpatient Hospitalization expenditures as measured through Medicaid claims data
Time Frame: (Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
We will use Medicaid claims and enrollment expenditure data to examine changes in inpatient hospitalization expenditures between the three groups of participants across baseline, 12 months, 24 months and 36 months.
|
(Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
Changes in Outpatient expenditures as measured through Medicaid claims data
Time Frame: (Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
We will use Medicaid claims and enrollment expenditure data to examine changes in outpatient expenditures between the three groups of participants across baseline, 12 months, 24 months and 36 months.
|
(Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
Changes in Emergency Department expenditures as measured through Medicaid claims data
Time Frame: (Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
We will use Medicaid claims and enrollment expenditure data to examine changes in emergency department expenditures between the three groups of participants across baseline, 12 months, 24 months and 36 months.
|
(Change) baseline, 12 months, 24 months, 36 months, and 1 year after month 36
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elizabeth Shenkman, Ph.D., University of Florida
- Study Director: Kimberly Case, Ph.D., University of Florida
- Study Director: Dena Stoner, Texas Health and Human Services Commission
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- Heart Failure
- Schizophrenia
- Asthma
- Neoplasms
- Cerebrovascular Disease
- Intracranial Injury
- HIV/AIDs
- Hereditary and Degenerative Diseases of the Central Nervous System
- Disorders of the Peripheral Nervous System
- Rheumatoid Arthritis and Other Inflammatory Polyarthropathies
- History of hepatitis C
- Episodic Mood Disorders
- Delusional Disorders
- Other Non-Organic Psychoses
- Organic Psychotic Conditions
- Neurotic Disorders
- Other Non-Psychotic Mental Disorders
Additional Relevant MeSH Terms
Other Study ID Numbers
- 168-2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Mental Illness
-
VA Office of Research and DevelopmentCompleted
-
VA Palo Alto Health Care SystemUS Department of Veterans Affairs; Veterans Affairs Office of Connected CareCompletedChronic Disease, Mental IllnessUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingChronic Medical ConditionUnited States
-
University of ValenciaUnknownChronic Medical IllnessSpain
-
University of British ColumbiaCompletedChildren Receiving Ventilation at Home for Chronic Illness or DiseaseCanada
-
RANDNational Institute of Mental Health (NIMH); University of California, Los AngelesUnknownSchizophrenia | Bipolar Disorder | Major Depression | Chronic Mental IllnessUnited States
-
The Hospital for Sick ChildrenUniversity of Toronto; Mind and Life Institute, Hadley, MassachusettsCompletedMental Health Impairment | Chronic Illness
-
National Institutes of Health Clinical Center (CC)CompletedSevere Chronic IllnessUnited States
-
University of Witten/HerdeckeUnknown
-
University of Alabama, TuscaloosaNational Institute of Nursing Research (NINR)CompletedPain | Palliative Care | Retention Disorders, Cognitive | Other Chronic IllnessUnited States
Clinical Trials on Patient-Directed Wellness Account
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Baylor Research InstituteCompleted
-
University of Colorado, DenverPatient-Centered Outcomes Research Institute; Mayo Clinic; University of Michigan and other collaboratorsRecruitingCommunication DisabilitiesUnited States
-
University of UtahNew York UniversityEnrolling by invitationCancer | Risk Reduction BehaviorUnited States
-
Shepherd Center, Atlanta GAPatient-Centered Outcomes Research InstituteUnknownSpinal Cord Injury | Peer Group
-
Felton InstitutePatient-Centered Outcomes Research Institute; University of New MexicoCompleted
-
Teachers College, Columbia UniversityRecruitingDepression | Anxiety | Distress, Emotional | Emotional DysfunctionUnited States
-
University of PittsburghUPMC Center for High-Value Health Care; Western Psychiatric Institute and Clinic... and other collaboratorsCompletedVascular Diseases | Cardiovascular Disease | Chronic Disease | Diabetes Mellitus Type 2 | Mental Health | Substance-related Disorders | Behavioral HealthUnited States
-
Agency for Healthcare Research and Quality (AHRQ)CompletedPatient-centered CareUnited States
-
Radboud University Medical CenterZorgverzekeraar CZ; Scientific Institute for Dutch Pharmacists, The NetherlandsCompletedBenzodiazepines Therapeutic UseNetherlands